If you’ve researched oral probiotics at all, you’ve encountered Lactobacillus reuteri. It appears in most credible oral health supplement formulas and in most clinical trials examining probiotic effects on gum health. Understanding why — what’s specific about this strain and what the evidence actually demonstrates — is worth doing if you’re deciding whether oral probiotics make sense for you.
What makes L. reuteri distinctive as an oral probiotic
Most probiotic strains were selected for gut health applications — they survive stomach acid, colonize intestinal mucosa, and have gut benefits. Their behavior in the oral cavity, which has a completely different microbial environment, pH, and immune context, was largely an afterthought. L. reuteri is different in that it has been specifically studied for oral colonization and oral health outcomes. It’s naturally found in the oral microbiome of healthy humans and has evolved mechanisms specifically suited to the oral environment. It produces two antimicrobial compounds — reuterin (3-hydroxypropionaldehyde) and reutericyclin — with broad-spectrum activity against harmful oral bacteria while leaving commensal species largely intact. This selectivity is what distinguishes it from antiseptic approaches that kill indiscriminately.
What the clinical trials show
The most rigorous research uses specific strains: ATCC PTA 5289 and DSM 17938, often combined. A 2006 randomized double-blind trial: subjects using L. reuteri lozenges for 4 weeks showed significant reductions in gingival bleeding index, plaque index, and pathogenic bacterial counts compared to placebo. A 2010 study: L. reuteri lozenges significantly reduced salivary Mutans streptococci counts over 12 weeks, with effects persisting 4 weeks after cessation. A 2023 systematic review and meta-analysis pooling 12 RCTs (Journal of Clinical Periodontology): statistically significant improvements in gingival bleeding index (standardized mean difference -0.89), plaque index (-0.67), and clinical attachment level (+0.41 mm) compared to control groups. These are clinically meaningful differences.
The delivery question
The research has clarified that delivery method matters: chewable or dissolvable tablets are more effective for oral colonization than swallowed capsules that primarily colonize the gut. Both ProDentim and GumAktiv use chewable tablet formats and list L. reuteri as a primary strain — aligning with the evidence-based approach. Our supplement comparison covers all five major products.
Educational content. Not medical or dental advice.